Spyros Papapetropoulos - 04 Jun 2025 Form 4 Insider Report for Lipocine Inc. (LPCN)

Reporting relationship: Director
Issuer ticker: LPCN
Reported as of: 04 Jun 2025
Net transaction value: +$5,645
SEC form: 4
Accepted by SEC: 05 Jun 2025, 16:06:40 UTC
Prior SEC filing: 18 Apr 2025
Next SEC filing: 02 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Spyros Papapetropoulos

Key filing fact

Spyros Papapetropoulos filed Form 4 for Lipocine Inc. (LPCN) on 05 Jun 2025.

Key facts

This page summarizes Spyros Papapetropoulos's Form 4 filing for Lipocine Inc. (LPCN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Jun 2025, 16:06.

Change

Previous filing in this sequence was filed on 18 Apr 2025.
Current net transaction value: +$5,645.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001832694 Primary reporting owner

Papapetropoulos Spyros

Relationship: Director
Address: 675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY
Signature: /s/ Spyros Papapetropoulos
Signature date: 05 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LPCN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $5,645
Shares: +1,764
Change %: +33%
Price: $3.20
Shares after: 7,174
Date: 04 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,764
Exercise price: $3.20
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

100% vesting one year from date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .